Literature DB >> 9673566

Interleukin-6 levels in colorectal cancer tissues.

H Komoda1, Y Tanaka, M Honda, Y Matsuo, K Hazama, T Takao.   

Abstract

Interleukin-6 (IL-6) levels in cancer tissues of 32 patients with colorectal cancer were measured and analyzed in relation to the clinico-pathologic findings. The IL-6 level in cancer tissues was 81.1 +/- 118.0 pg/mg protein, which was significantly higher than the 11.2 +/- 20.8 pg/mg protein in normal colorectal tissues (p = 0.028). IL-6 levels in cancer tissues showed no correlation with the incidence of venous invasion, lymphatic invasion, lymph node involvement, or liver metastasis. The IL-6 level in cancer tissue tended to decrease as the cancer penetration extended. Our results suggest that IL-6 may play a role in human colorectal cancer growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673566     DOI: 10.1007/s002689900489

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 2.  Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells.

Authors:  Muriel Mathonnet; Aurelie Perraud; Niki Christou; Hussein Akil; Carole Melin; Serge Battu; Marie-Odile Jauberteau; Yves Denizot
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

4.  Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

Authors:  Nikolaos I Nikiteas; Nikolaos Tzanakis; Maria Gazouli; George Rallis; Kessaris Daniilidis; George Theodoropoulos; Alkiviadis Kostakis; George Peros
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.

Authors:  Fanyin Meng; Yoko Yamagiwa; Silvia Taffetani; Jiahuai Han; Tushar Patel
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-25       Impact factor: 4.249

6.  The role of microRNA-30c in targeting interleukin 6, as an inflammatory cytokine, in the mesenchymal stem cell: a therapeutic approach in colorectal cancer.

Authors:  Mohamad Mahjoor; Hamed Afkhami; Mohammad Najafi; Atieh Nasr; Samaneh Khorrami
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-25       Impact factor: 4.322

7.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

Review 8.  New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Authors:  Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 46.802

Review 9.  Interleukin-6--a key regulator of colorectal cancer development.

Authors:  Maximilian J Waldner; Sebastian Foersch; Markus F Neurath
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

10.  Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.

Authors:  C Gordziel; J Bratsch; R Moriggl; T Knösel; K Friedrich
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.